MedTrace Logo

Withdraw Drug in Stable IgG4-Related Disease

NCT04124861 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 138

Last updated 2022-02-07

No results posted yet for this study

Summary

Evaluation and prediction of relapse risk after glucocorticoid or immunosuppressant withdrawal in patients with stable IgG4 related disease: a prospective cohort study from china.

Conditions

Interventions

DRUG

Drug free, IS monotherapy and GC combined with IS

Follow-up intervals: Every 3 months (3th, 6th, 9th, 12th, 15th, 18th month).

Sponsors & Collaborators

  • Chinese PLA General Hospital

    collaborator OTHER

  • Peking University People's Hospital

    collaborator OTHER

  • The People's Hospital of Hebei Province

    collaborator OTHER

  • Shengjing Hospital

    collaborator OTHER

  • Tongji Hospital

    collaborator OTHER

  • Peking Union Medical College Hospital

    lead OTHER

Principal Investigators

  • Wen Zhang, MD. · Peking Union Medical College Hospital

  • Yunyun Fei, MD · Peking Union Medical College Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-23
Primary Completion
2022-12-30
Completion
2023-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04124861 on ClinicalTrials.gov